ALISON CHALKER, PH.D.
PORTFOLIO STRATEGY & DATA SCIENCES INTEGRATION LEADER
As Strategic Portfolio and Data Sciences Integration Leader for Neuroscience at Janssen Research & Development (R&D), Alison Chalker, Ph.D. leads a team responsible for driving Therapeutic Area operations, Neuroscience portfolio management and strategy, and integration of data science approaches in R&D programs from discovery to commercialization.
With more than three decades of experience, Alison began her career at GSK, where she led a team in exploring novel therapeutics for unusual bacterial pathogens, utilizing bioinformatic, genetic, and biochemical techniques. During her career, Alison has led global cross-functional drug development programs for small molecules and biologics, from discovery through lifecycle management, in Anti-Infectives, Cardiovascular, Gastro-intestinal, Neurology, Psychiatry, and Oncology; and has held Department Head roles in Regulatory Affairs and Program Management.
Alison received a bachelor’s degree in Microbiology from Bristol University and a doctorate in Molecular Microbiology from the University of Edinburgh, where she also conducted postdoctoral research. She is passionate about the transformational potential of the empowered cross-functional team; conducting drug development with an unwavering sense of accountability to our patients and customers; and developing the next generation of pharma leaders.